Elaine Nguyen to Treatment Outcome
This is a "connection" page, showing publications Elaine Nguyen has written about Treatment Outcome.
Connection Strength
0.382
-
Nguyen E, Coleman CI, Nair S, Weeda ER. Cost-utility of empagliflozin in patients with type 2 diabetes at high cardiovascular risk. J Diabetes Complications. 2018 02; 32(2):210-215.
Score: 0.117
-
Nguyen E, Weeda ER, Sobieraj DM, Bookhart BK, Piech CT, Coleman CI. Impact of non-medical switching on clinical and economic outcomes, resource utilization and medication-taking behavior: a systematic literature review. Curr Med Res Opin. 2016 07; 32(7):1281-90.
Score: 0.105
-
Nguyen E, Weeda ER, White CM. A Review of New Pharmacologic Treatments for Patients With Chronic Heart Failure With Reduced Ejection Fraction. J Clin Pharmacol. 2016 08; 56(8):936-47.
Score: 0.103
-
Coleman CI, Weeda ER, Nguyen E, Bunz TJ, Sood NA. Effectiveness and safety of rivaroxaban vs. warfarin in patients 80+ years of age with non-valvular atrial fibrillation. Eur Heart J Qual Care Clin Outcomes. 2018 10 01; 4(4):328-329.
Score: 0.031
-
Weeda ER, Nguyen E, White CM. Role of Ivabradine in the Treatment of Patients With Cardiovascular Disease. Ann Pharmacother. 2016 06; 50(6):475-85.
Score: 0.026